Newer approaches to the diagnosis of early onset neonatal sepsis.
Accurate and timely diagnosis of early onset neonatal sepsis remains challenging to the clinician and the laboratory. A test with a rapid turnaround time with 100% sensitivity, rather than high specificity, which allows accurate diagnosis and appropriate antimicrobial treatment or which allows antibiotics to be safely withheld in non-infected infants, is desirable. Many potential markers (acute phase reactants, cell surface markers, cytokines) are not routinely available to the laboratory, and most likely combinations of markers will ensure greater diagnostic accuracy. In the future, molecular biology techniques offer the prospect of rapid identification of both pathogens and antimicrobial resistance markers.
Mishra
U K
UK
Newborn Services, Royal Women's Hospital, Victoria, Australia.
Jacobs
S E
SE
Doyle
L W
LW
Garland
S M
SM
D000210:Acute-Phase Reaction; D000954:Antigens, Surface / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D016207:Cytokines / Q000032:analysis; D042241:Early Diagnosis; D005821:Genetic Techniques; D016179:Granulocyte Colony-Stimulating Factor / Q000032:analysis; D006801:Humans; D018743:Perinatal Care / Q000379:methods*; D011296:Prenatal Diagnosis / Q000379:methods*; D040901:Proteomics; D018805:Sepsis / Q000175:diagnosis*
D000954:Antigens, Surface; D015415:Biomarkers; D016207:Cytokines; D016179:Granulocyte Colony-Stimulating Factor